MedTrace Logo

Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV

NCT01709448 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2012-10-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether a model can be created to predict the progression of early anal cancer precursor lesions in HIV using potential predictors such as: HIV treatment history, smoking history, sexual history, human papillomavirus viral load, human papillomavirus protein expression, and cell markers associated with progression of HPV-related lesions.

Conditions

  • Neoplasms, Squamous Cell
  • Papillomavirus Infections

Sponsors & Collaborators

  • University of Cincinnati

    collaborator OTHER

  • Cincinnati VA Medical Center

    collaborator OTHER_GOV

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Jaime C Robertson, MD · University of Cincinnati

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01709448 on ClinicalTrials.gov